2m 2m 2m 2m 2m 2m 2m
Axsome Therapeut (AXSM)
NASDAQ
$148.22-$1.02 (-0.68%)
Price as of Nov 12, 2026 8:34 AM EST- $7.9BMarket Cap
- 5.95%1-Year Change
- BiotechnologyIndustry
Axsome Therapeut (AXSM)
$148.22-$1.02 (-0.68%)
AXSM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $149.24 | ||
Change | +$8.27 (+5.87%) | ||
Open | $141.41 | ||
High | $151.31 | ||
Low | $141.35 | ||
Previous Close | $140.97 | ||
Volume | 1,072,510 | ||
30-Day Average Volume | 1,105,500 | ||
1-Week Change | 8.93% | ||
1-Month Change | -11.35% | ||
1-Year Change | 5.95% | ||
3-Year Change | 159.91% | ||
5-Year Change | 277.63% | ||
Fundamentals | |||
Shares Outstanding | 52.6M | ||
Total Assets | $826.8M | ||
Market Cap | $7.9B | ||
Enterprise Value | $7.7B | ||
Period: QTR TTM FY | |||
Revenue | $250.0M | ||
Net Income | -$12.9M | ||
Free Cash Flow | -$9.7M | ||
EBIT | -$9.4M | ||
EBITDA | -$7.8M | ||
Net Working Capital | $214.9M | ||
EPS | -$0.25 | ||
Enterprise Value/EBITDA | -994 | ||
Enterprise Value/Revenue | 31 | ||
P/B | 74 | ||
P/E | -597 | ||
PEG | -8 | ||
Price/Free Cash Flow | -812 | ||
Price/Operating Cash Flow | -829 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue